Home / Sell by State / New York / New York, NY
New York City · Sell-Side M&A
The aesthetics consolidation wave is landing in Manhattan. In February 2025 a PE-backed platform acquired a two-location Manhattan med spa, the first named deal of its kind in this cycle. That demand is real, and so is New York City's tightening enforcement on med-spa structure. We represent New York City owners only, and we build the deal around the rules and the buyers who are actually closing here.
A confidential ballpark in under two minutes, no email required.
The State Rules, In Brief
New York reserves practice ownership for licensed physicians, so a non-physician cannot own a medical practice, employ the clinicians, or profit directly from the medical business. The lawful path is the friendly-PC and MSO model: a professional corporation or PLLC owned by a licensed New York physician holds the clinical practice, and a separate management services organization, the part a non-physician investor owns and funds, provides non-clinical services for a fixed fee. The MSO is what gets bought and sold, which is why a New York City sale is a structured transaction, never a simple stock sale. New York also restricts management fees tied to a percentage of clinical revenue, treating them as prohibited fee-splitting, and the Department of Health monitors MSO arrangements for corporate-practice violations. That is the short version, focused on what matters for a New York City deal. The full statutory anchors, the Business Corporation Law and Education Law citations, and the deeper compliance treatment all live on our New York state hub.
| Measure | Figure | Note |
|---|---|---|
| New York State med spas | ~540 | Top-five market by count |
| National rank by count | 4th | Behind FL ~1,180 and CA ~1,150 |
| Out of U.S. total | 10,488 | All U.S. med spas |
| NYC positioning | Top 3 | One of the most competitive U.S. markets |
No independently citable med-spa count exists for New York City alone, so density is framed at the verified state level. New York State counts roughly 540 medical spas, fourth nationally out of 10,488. AmSpa names New York City specifically as a market driving Northeast expansion. Treat the figures as data-set estimates, not a state-certified statistic.
Market Reality
New York State counts roughly 540 medical spas in a data set drawing on AmSpa's 2024 State of the Medical Spa Industry report and US Census County Business Patterns, ranking it fourth nationally out of 10,488 med spas in the United States, behind Florida at roughly 1,180 and California at roughly 1,150. AmSpa names New York City specifically as a market driving Northeast expansion of advanced med-spa services. There is no honest metro-level count to quote, so we frame density at the state level and let the deal record speak: a named PE platform acquired a two-location Manhattan med spa in February 2025. That is the consolidation demand a New York City seller is sitting on.
Run my numbers →See Your Number First
A confidential ballpark in under two minutes. No email required to see your range. The estimate is generated on your device. Nothing is stored or sent unless you choose to continue.
Step 1 · Instant ballpark
Estimated enterprise value
Practices like yours trade around 2.6x – 5.3x adjusted earnings.
What raises your number
What lowers your number
Step 2 · What you receive when you continue
Your custom valuation report. Comparable transactions, your likely buyer pool, and timing analysis.
Your buyer-readiness scorecard. The specific moves that raise your multiple before you go to market.
A confidential 30-minute strategy call with Bill Walker. No obligation, no pressure.
Your information is never shared, and we have never broken a client's confidentiality.
Estimate only. A ballpark from limited inputs plus published industry M&A benchmarks.
What Moves Value Here
No New York, NY-specific sale multiple is published, and we will not invent one. The honest anchor is the national vertical range already on our med spa, cosmetic dermatology, and plastic surgery hubs. What changes a New York City seller's realized value is how the deal has to be built. Value sits in the MSO, and how cleanly that management company clears state review and local enforcement decides what a buyer will actually pay.
Most of the enterprise value a non-physician buyer can acquire is the management company, not the professional corporation. A buyer pays for the MSO's defensible cash flow and the durability of the PC relationship. A New York City practice already cleanly split into a compliant MSO transacts faster and holds its value.
See the local layer →With four agencies actively inspecting New York City med spas, a structure exposed to compliance challenge invites re-trading and discounts. A defensible MSO and management agreement is what holds your price through diligence in this city. Clean it up before market.
Why structure decides price →New York City is one of the highest-demand aesthetics markets in the country, and a named PE buyer just acted on it. Stronger buyer competition for well-run, compliant platforms supports the national range. It does not create a published city multiple.
Who is buying →We reference the national vertical multiple range published on our practice-type hubs. We do not publish a New York, NY-specific multiple, because none exists in a citable, defensible form. In New York City, value is moved more by structure, compliance readiness, and verified buyer competition than by a geographic multiple. Your real range comes from a confidential, practice-specific analysis of your earnings, your MSO structure, and your comps.
Who Is Actually Buying in New York City
A New York City seller is not waiting on hypothetical demand. In February 2025, AYA Medical Spa, backed by Atlanta private equity firm Eagle Merchant Partners, entered New York by acquiring Tribeca MedSpa, which runs two locations in Manhattan. AYA's leadership described the move as expanding its footprint in a key market. That is a named, public, in-market transaction, not a national press release that mentions the city in passing. It is the clearest signal yet that well-capitalized buyers are putting capital to work in Manhattan, and it sets the tone for what a New York City owner can take to market.
Detail bars are redacted by design. Every name and activity claim on this board is published from verifiable records; anything beyond the public record stays confidential. AYA Medical Spa and Eagle Merchant Partners are the verified, in-market proof point, documented via a February 24, 2025 PRNewswire press release on the Tribeca MedSpa acquisition. Princeton Medspa Partners (BC Partners) is a statewide platform whose verified New York deal is in Saratoga Springs, upstate, not the New York City metro, so we name it as a statewide buyer rather than an NYC in-market acquirer. JECT is a multi-borough New York City aesthetics operator that also runs in the Hamptons and Westchester, cited as evidence of the affluent tri-state demand corridor. No local-only buyer is invented.
New York City Sale FAQ
There is a documented, in-market proof point. In February 2025, AYA Medical Spa, backed by Atlanta private equity firm Eagle Merchant Partners, entered New York by acquiring Tribeca MedSpa, a practice that runs two locations in Manhattan. AYA’s leadership described the deal as expanding its footprint in a key market, which is the consolidation signal a New York City seller is sitting on. Beyond that named transaction, well-capitalized national platforms and PE-backed MSOs treat the city as a priority market. We name AYA and Eagle Merchant Partners because the deal is public and verifiable, and we will never assert a local-only buyer that does not exist.
New York State law sets the rules, but New York City adds a live local enforcement layer on top of them. In December 2025, a joint operation involving the New York City Council, the New York City Office of Inspector General, the New York State Department of Health, and the New York State Education Department published a med-spa enforcement report. Of the 15 New York City locations inspected, every one was found to have health and safety violations, and the report targeted non-physician ownership and improper MSO and PC structures specifically. For a seller, that means a buyer’s diligence in the city scrutinizes structure and compliance harder than the statute alone implies. A clean friendly-PC and MSO setup is the difference between a smooth close and a re-trade.
No. There is no published New York, NY-specific multiple, and we will not quote one. What we use is the national vertical range for your practice type, then we explain how New York law and the New York City market move structure and value. In New York, value sits in the MSO, not the professional corporation, and the management fee has to be structured to survive state review of fee-splitting. A New York City practice that is already cleanly separated into a compliant MSO, with a defensible management agreement, transacts faster and holds its value, especially given the city’s active enforcement. Your real number comes from a confidential, practice-specific analysis.
New York enforces the corporate practice of medicine doctrine strictly, so a non-physician individual or company cannot own a medical practice, employ physicians to deliver care, or profit directly from running a medical business. The lawful path is the friendly-PC and MSO model: a professional corporation or PLLC owned by a licensed New York physician holds the clinical practice, and a separate management services organization, the part a non-physician investor owns and funds, provides non-clinical services for a fixed fee. The MSO is what gets bought and sold. New York also restricts management fees tied to a percentage of clinical revenue as prohibited fee-splitting. For the full statutory treatment, see our New York state hub. This page focuses on how those rules play out in the New York City deal market.
New York State counts roughly 540 medical spas in a data set drawing on the American Med Spa Association 2024 State of the Medical Spa Industry report and US Census County Business Patterns, ranking it fourth nationally out of 10,488 med spas in the United States, behind Florida at roughly 1,180 and California at roughly 1,150. AmSpa names New York City specifically as a market driving Northeast expansion of advanced med-spa services. There is no independently citable count of med spas for the city alone, so we frame density at the verified state level and rely on the qualitative reality that New York City is one of the most competitive aesthetics markets in the country. Treat the figures as data-set estimates, not a state-certified statistic.
In practice, yes, if your buyer is a private equity firm or a non-physician platform. Because New York reserves practice ownership for licensed professionals, most enterprise value a non-physician buyer can acquire sits in the management company, not the professional corporation. A physician seller who has not separated the business into a clean PC and MSO structure has a deal-readiness gap that suppresses both buyer interest and price, and in New York City the local enforcement spotlight makes that gap costlier still. Getting the structure right before going to market is the single biggest lever a New York City seller controls, and it is one of the first things we map.
Where To Go Next
The full corporate-practice-of-medicine treatment: the friendly-PC and MSO model, the statutory anchors, and the fee-splitting rules that govern every New York sale.
Read the New York state hub →How recurring and membership revenue, provider capacity, and key-person risk set a med spa's value, paired with the New York City structure work above.
Med spa sell-side →How a cosmetic dermatology practice is valued for sale, and where the structured-deal work overlaps with New York City's enforcement environment.
Cosmetic derm sell-side →New York City's Unique Local Layer
New York State already runs one of the strictest corporate-practice-of-medicine regimes in the country, and the full statutory treatment lives on our New York state hub. What makes New York City different is a live, coordinated enforcement operation sitting on top of that state law, and it directly affects how a buyer values your practice.
The enforcement layer is not one regulator. In December 2025, a joint operation involving the New York City Council, the New York City Office of Inspector General, the New York State Department of Health, and the New York State Education Department published a med-spa enforcement report. That coordination is what makes New York City compliance review tougher than the statute alone implies.
Of the 15 New York City med-spa locations the December 2025 report inspected, every single one was found to have health and safety violations. The report specifically targeted non-physician ownership and improper MSO and PC structures, the exact arrangements a buyer's diligence cares about most.
The report's focus on non-physician ownership and management arrangements means a New York City buyer treats your friendly-PC and MSO separation as a primary diligence item, not a footnote. The report also recommends that esthetician businesses post consumer notices distinguishing them from licensed medical providers.
In a market with active local enforcement, a practice already separated into a compliant, defensible MSO carries less perceived risk. Less risk for the buyer is a higher, more durable price for the seller. In New York City, getting the structure right before market is not paperwork. It is value.
Who you work with
Bill Walker founded Aesthetic Brokers after leading mergers and acquisitions for a large private-equity-backed healthcare services organization. Before that he flew for the Marine Corps at the Presidential Helicopter Squadron and commanded a squadron in combat. He knows how an investor values a practice, and how to make sure that value lands with you, not the buyer.
Talk with Bill about your practiceStart with a confidential, two-minute read on where you stand.
